Immunosuppressant
Sirolimus reduce rejection rates when compared to control regimens - daynighthealthcare
- Rapamune (sirolimus) is an immunosuppressant agent developed to reduce organ rejection in patients receiving kidney transplants. » By John Wharton, edited on June 17 2015 In Press Releases and Company Profiles |